- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Life Science & Biotech
Most of Indiana's largest public companies enjoyed strong 2012
June 15, 2013
Angie's List turned a profit for the first time in nearly two decades.
MoreLilly halts trial of experimental Alzheimers drug
June 14, 2013
The trial ended after participants showed abnormal liver biochemistry, the Indianapolis-based drugmaker said Thursday in a
statement.
MoreBio-Response expanding in Hendricks County
June 10, 2013
IBJ StaffWastewater equipment maker is moving to a Danville business park to build a $1.1 million facility.
MoreNew institute aims to attract 100 research scientists to Indiana
May 30, 2013
J.K. WallThe $360 million initiative will be formally launched on Thursday by Gov. Mike Pence, executives of five major life sciences
companies and officials of the state’s research universities.
MoreMobile health apps could cut into state companies' market share
May 18, 2013
J.K. WallThe future of Indiana’s sprawling health care and life sciences industry might be threatened by an unlikely source:
smartphone apps.
MorePINCUS: State needs better life sciences startup ecosystem
May 18, 2013
Jack Pincus / Special to IBJIndiana’s life sciences sector is mostly composed of legacy companies.
MoreReport: Roche mulls sale of blood-glucose monitor business
May 17, 2013
J.K. WallRoche Diagnostics Corp. is considering a sale of its blood-glucose meter business, a move that would cast uncertainty over
the nearly 1,000 people working for its diabetes business in Indianapolis.
MorePANEL: Life sciences will see radically different future
May 17, 2013
IBJ convened a panel of experts at its Life Sciences Power Breakfast on May 10 to talk about the industry issues
of venture capital, digital health innovations and research university entrepreneurship.
MorePanel members included Kristin Eilenberg, CEO, Lodestone Logic, Infuse Accelerator; Philip S. Low, Purdue University professor of chemistry, founder and chief science officer at Endocyte Inc. and On Target Laboratories LLC; R. Matthew Neff, president, CHV Capital Inc.; Brian Stemme, project director; BioCrossroads; Brian S. Williams, director, Global Healthcare Strategy, PricewaterhouseCoopers International Ltd.; and Raul Zaveleta, CEO, Indigo BioSystems Inc.
The following is an unedited transcript of the discussion.
New seed fund aims to make Indiana a hotbed for digital health startups
May 4, 2013
J.K. WallInfuse Accelerator hopes to make early-stage investments in 12 to 15 companies a year.
MoreLilly suing J&J for patent rights in Alzheimer's drug race
April 25, 2013
Bloomberg NewsEli Lilly and Co. is seeking to revoke a patent held by a Johnson & Johnson unit, arguing at a London court it might delay
availability of a potential treatment for Alzheimer’s disease.
MoreDow AgroSciences grows sales, earnings to new heights
April 25, 2013
Mason King, Bloomberg NewsRecord sales for seeds and new crop protection products helped boost revenue 14 percent at Indianapolis-based Dow AgroSciences
LLC in its new fiscal year.
MoreLilly seeks $30.6M in tax breaks on downtown projects
April 15, 2013
Mason KingIndianapolis development officials on Wednesday will weigh the 10-year requests from the pharmaceuticals giant related to
a new manufacturing plant and improvements to existing operations downtown.
MoreIU medical school's push to launch startups bears fruit
April 13, 2013
J.K. WallThe Indiana University School of Medicine has launched 12 companies in the past 18 months—a burst of startup activity
the school has never seen before.
MoreExpected revenue slump spurs Lilly to cut sales force
April 11, 2013
J.K. WallThe Indianapolis pharmaceuticals giant said Thursday that it would lay off hundreds of U.S. sales reps, as it prepares for
the loss of patent protection on two of its best-selling drugs.
MoreCity to buy key parcel for 16th Street tech corridor
April 6, 2013
Scott OlsonThe city of Indianapolis is poised to pay Citizens Energy Group $6.5 million to buy a key parcel of real estate it’s
targeting as the centerpiece of its ambitious 16 Tech project.
MoreLilly pulls back from proposals lowering takeover barriers
April 6, 2013
Greg AndrewsFortunately, a Lilly takeover looks less likely today than it has in a long time—for both obvious and more subtle reasons.
MoreLilly to spend $180M doubling size of Indy plant
April 2, 2013
The new investment will bring the plant's total price tag to $320 million as the pharmaceutical giant seeks to increase production
of insulin and related products.
MoreSherry Labs snapped up by Netherlands corporation
April 1, 2013
Jeff NewmanThe materials-testing business with nearly 300 employees has been acquired by Element Materials Technology. Sherry had been
owned by a group of well-connected central Indiana businessmen.
MoreProfits at center of biosimilars debate
March 18, 2013
J.K. WallHouse Bill 1315, which is scheduled for a Senate floor hearing on Monday, would require pharmacists to check with a patient’s
physician before automatically substituting a generic version of a biotech drug for a brand-name version.
MoreMedical device maker moving to Noblesville, adding jobs
March 12, 2013
Fishers-based Nexxt Spine LLC, a manufacturer of spinal implants, is consolidating operations and moving its headquarters
and manufacturing facility to Noblesville.
MoreQ&A
March 11, 2013
J.K. WallMike Sherman, the chief financial officer at West Lafayette-based Endocyte Inc., talked about how the drug
firm’s funding partnership with New Jersey-based Merck & Co. Inc. has helped accelerate development of the company’s
pipeline, which is branching out into drugs to treat cancers of the lung, prostate and breast.
MoreLilly sues Genentech to invalidate Erbitux-related patents
March 2, 2013
Bloomberg NewsEli Lilly and Co. has sued Roche Holding AG’s Genentech unit, asking a court to invalidate patents used to make treatments
for cancer and autoimmune diseases.
MoreDow AgroSciences wins bid to overturn pesticide guidelines
February 21, 2013
Bloomberg NewsIndianapolis-based Dow Agrosciences LLC and two other pesticide makers won a bid to overturn U.S. National Marine Fisheries
Service proposals to protect salmon when an appeals court found the agency’s decision “arbitrary and capricious.”
MoreLilly to expand partnership with diagnostic firm
February 14, 2013
IBJ Staff and Associated PressDiagnostic products maker Qiagen NV said Wednesday that it will work with Eli Lilly and Co. to develop new tests that could
identify patients who could be helped by Lilly's drugs.
More'12 worst year for life sciences since 1990s
February 11, 2013
J.K. WallTo understand why Indiana’s life sciences entrepreneurs are frustrated with the flow of venture capital, look no further
than this statistic from a recent PricewaterhouseCoopers report: 2012 was the slowest year for first-time life sciences investment
since 1995.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Saw the Indy Men's Chorus "Music of Gilbert & Sullivan" at the Indiana Historical Society on Sunday evening.
Temporary workers are not "tools" they are people and companies that keep large amounts of temp staff are cheating.
I miss having them around. I hope one of their stores is in the general Meridian/86th Street area. I will make good use of it.
The Fringe! Plus, the simple fact that there are so many local faves in such close proximity to each other.
I remenber, watching the toll road, being built, through South Bend, when I was 10 years old. I believe, back then that it was estimated, that the toll road, would be paid for in 20 years and then it would be free. I am now 71, what happened? Since the power is in the people, by that, I mean that, we the people are in total control of everything. I, suggest that no one ever use the toll road again, let it go broke. We the people can control the price of everything, from groceries to gas, if we would just do it. If we don't pay the asking price, the sellers will lower the price and if we wait awhile, they will lower the price to what we accept as reasonable. I would like to know why a highway like interstate 94, is so well maintained, a much better highway, than the toll road, but has no tolls. I would also like to know why, a sitting governor, with a term limit, maximum of eight years, can lease, public property, for 75 years. Even though I have transponders in both of my trucks and will not be affected by the increase, I have been and will contine to avoid using the toll road. I make many trips from northern Indiana to Chicago, every year, and I prefer the better highway, I94!